The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.

The aim of this study was to examine the role of HDL subparticles with apolipoprotein (apo) A-I alone (LpA-I) and with apoA-I and apoA-II (LpA-I/A-II) in predicting coronary artery disease. Concentrations of these HDL subparticles were compared in 184 subjects with angiographically confirmed significant coronary artery disease (> 50% stenosis of at least one vessel) and 191 age- and sex-matched control subjects without clinical coronary artery disease. LpA-I and LpA-I/A-II were measured with magnetic beads coated with anti-apoA-II antibodies to separate particles containing apoA-II from plasma. Total plasma cholesterol and triglyceride levels were similar in both groups. Although subjects with coronary artery disease had lower HDL cholesterol, plasma apoA-I, LpA-I, and LpA-I/A-II than age- and sex-matched control subjects without coronary artery disease, plasma apoA-I was the best predictor of coronary artery disease. In conclusion, LpA-I and LpA-I/A-II are lower in subjects with coronary artery disease but do not add to plasma apoA-I in predicting the presence of coronary artery disease.

[1]  B. Kottke,et al.  Immunomagnetic separation of subpopulations of apolipoprotein A-I. , 1994, Mayo Clinic proceedings.

[2]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[3]  A. Mendez,et al.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux. , 1993, The Journal of clinical investigation.

[4]  A. Evans,et al.  A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  W. J. Johnson,et al.  Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. , 1991, Journal of lipid research.

[6]  D. Rader,et al.  In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. , 1991, Journal of lipid research.

[7]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[8]  H. Wilson,et al.  The distribution of high-density lipoprotein subfractions in coronary survivors. , 1990, Biochemical Society transactions.

[9]  J. Auget,et al.  Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery. , 1990, Clinical chemistry.

[10]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[11]  D. Erkelens,et al.  Apolipoproteins in lipid transport, an impressionist view. , 1989, Postgraduate medical journal.

[12]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[13]  J. Fruchart,et al.  Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.

[14]  N. Miller.  Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. , 1987, American heart journal.

[15]  J. Fruchart,et al.  Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.

[16]  A. Zinsmeister,et al.  Apolipoproteins and coronary artery disease. , 1986, Mayo Clinic proceedings.

[17]  J. Albers,et al.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. , 1984, The Journal of biological chemistry.

[18]  J. Kane,et al.  Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[20]  J. Kane,et al.  Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. , 1982, Journal of lipid research.

[21]  H. van Kley,et al.  Easy measurement of viscosity of semi-micro serum samples. , 1981, Clinical chemistry.

[22]  F. Grillo,et al.  Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. , 1981, Clinical chemistry.

[23]  F. Grillo,et al.  Improved method for determination of high-density-lipoprotein cholesterol II. Enzymic determination of cholesterol in high-density lipoprotein fractions with a sensitive reagent. , 1981, Clinical chemistry.

[24]  L. Wilhelmsen,et al.  Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. , 1980, Atherosclerosis.

[25]  Y. Marcel,et al.  Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Mahley,et al.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. , 1980, Journal of lipid research.

[27]  P. Alaupovic.  Conceptual Development of the Classification Systems of Plasma Lipoproteins , 1972 .

[28]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.